Latest / Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals
SURPASS-CVOT and the Case for Dual Incretin Therapy
Luke Laffin, MD, and Steven Nissen, MD, discuss findings from SURPASS-CVOT, including a secondary analysis evaluating broader cardiovascular and renal outcomes with dual GLP-1 and GIP agonist therapy compared with a first-generation GLP-1 agent. The conversation examines outcomes of the therapy on all-cause mortality and the clinical implications for treating patients with diabetes and high cardiovascular risk.
View current clinical trials. https://my.clevelandclinic.org/departments/heart/clinical-trials
Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.